Hongchan An

824 total citations
35 papers, 482 citations indexed

About

Hongchan An is a scholar working on Molecular Biology, Organic Chemistry and Biochemistry. According to data from OpenAlex, Hongchan An has authored 35 papers receiving a total of 482 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 16 papers in Organic Chemistry and 8 papers in Biochemistry. Recurrent topics in Hongchan An's work include Synthetic Organic Chemistry Methods (7 papers), Chemical Synthesis and Analysis (6 papers) and Microbial Natural Products and Biosynthesis (5 papers). Hongchan An is often cited by papers focused on Synthetic Organic Chemistry Methods (7 papers), Chemical Synthesis and Analysis (6 papers) and Microbial Natural Products and Biosynthesis (5 papers). Hongchan An collaborates with scholars based in South Korea, United States and Sudan. Hongchan An's co-authors include Young‐Ger Suh, Ki Bum Hong, Jaehoon Sim, Kyeojin Kim, Jeeyeon Lee, Thomas Kodadek, Young Taek Han, Jaebong Jang, Jeewoo Lee and Hyun‐Ju Park and has published in prestigious journals such as Angewandte Chemie International Edition, Chemical Communications and Biochemical and Biophysical Research Communications.

In The Last Decade

Hongchan An

34 papers receiving 472 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hongchan An South Korea 14 228 180 65 57 34 35 482
Mitchell A. deLong United States 11 207 0.9× 128 0.7× 27 0.4× 49 0.9× 12 0.4× 29 676
Sharon Rossiter United Kingdom 12 244 1.1× 206 1.1× 24 0.4× 34 0.6× 273 8.0× 21 761
Madhu Sudhana Saddala United States 15 191 0.8× 100 0.6× 62 1.0× 30 0.5× 19 0.6× 42 515
Mustafa Güzel Türkiye 14 166 0.7× 177 1.0× 67 1.0× 22 0.4× 22 0.6× 41 467
Mingde Xia United States 14 145 0.6× 219 1.2× 113 1.7× 53 0.9× 26 0.8× 23 496
Kebin Wu United States 11 357 1.6× 91 0.5× 39 0.6× 22 0.4× 10 0.3× 19 515
Lamees Hegazy United States 13 191 0.8× 128 0.7× 75 1.2× 38 0.7× 30 0.9× 28 421
Jih‐Lie Tseng United States 13 248 1.1× 63 0.3× 38 0.6× 56 1.0× 46 1.4× 26 569
Hanwei Yin China 15 436 1.9× 131 0.7× 96 1.5× 34 0.6× 23 0.7× 23 678
Xuezhen Xu South Korea 7 187 0.8× 153 0.8× 49 0.8× 54 0.9× 18 0.5× 14 443

Countries citing papers authored by Hongchan An

Since Specialization
Citations

This map shows the geographic impact of Hongchan An's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongchan An with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongchan An more than expected).

Fields of papers citing papers by Hongchan An

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongchan An. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongchan An. The network helps show where Hongchan An may publish in the future.

Co-authorship network of co-authors of Hongchan An

This figure shows the co-authorship network connecting the top 25 collaborators of Hongchan An. A scholar is included among the top collaborators of Hongchan An based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongchan An. Hongchan An is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Lee, Jeong Hyeon, et al.. (2024). Semaxanib, a VEGF inhibitor, suppresses melanogenesis by modulating CRTC3 independently of VEGF signaling. Journal of Dermatological Science. 115(3). 121–129. 1 indexed citations
4.
Lee, Jae Kyun, et al.. (2023). Thio(seleno)cyano-difluoroalkylation of Alkenes Using Visible-Light Photocatalysis. Organic Letters. 25(19). 3564–3567. 21 indexed citations
6.
An, Hongchan, Seonghwan Hwang, Min‐Soo Kim, et al.. (2022). A bioisosteric approach to the discovery of novel N-aryl-N′-[4-(aryloxy)cyclohexyl]squaramide-based activators of eukaryotic initiation factor 2 alpha (eIF2α) phosphorylation. European Journal of Medicinal Chemistry. 239. 114501–114501. 4 indexed citations
7.
Shrestha, Aarajana, Su‐Jeong Lee, Yong Hyun Jeon, et al.. (2021). Targeting the Nuclear Receptor-Binding SET Domain Family of Histone Lysine Methyltransferases for Cancer Therapy: Recent Progress and Perspectives. Journal of Medicinal Chemistry. 64(20). 14913–14929. 23 indexed citations
8.
Abegg, Daniel, Ekaterina V. Vinogradova, Hongchan An, et al.. (2020). Physical and Functional Analysis of the Putative Rpn13 Inhibitor RA190. Cell chemical biology. 27(11). 1371–1382.e6. 16 indexed citations
9.
Doran, Todd M., et al.. (2019). Synthesis and screening of bead-displayed combinatorial libraries. Methods in enzymology on CD-ROM/Methods in enzymology. 622. 91–127. 9 indexed citations
10.
Lim, Changjin, Jaehoon Sim, Hwayoung Yun, et al.. (2017). Total synthesis of (+)-brasilenyne via concise construction of an oxonane framework containing a 1,3-cis,cis-diene. Chemical Communications. 54(5). 467–470. 5 indexed citations
11.
Kim, Kyeojin, Jong‐Min Park, Nam‐Jung Kim, et al.. (2016). Identification and Structural Analysis of New Nrf2 Activators by Mechanism‐Based Chemical Transformation of 15‐Deoxy‐Δ12, 14‐PGJ2. ChemBioChem. 17(20). 1900–1904. 2 indexed citations
12.
Kim, Kyeojin, Su‐Jung Kim, Young Taek Han, et al.. (2015). Identification of small molecule inhibitors of the STAT3 signaling pathway: Insights into their structural features and mode of action. Bioorganic & Medicinal Chemistry Letters. 25(22). 5444–5448. 12 indexed citations
13.
Lee, Seungbeom, Hongchan An, Dong‐Jo Chang, et al.. (2015). Total synthesis of (−)-deguelin via an iterative pyran-ring formation strategy. Chemical Communications. 51(43). 9026–9029. 14 indexed citations
14.
Lee, Ji Yeon, Seungbeom Lee, Sooyoung Chung, et al.. (2015). Identification of a novel circadian clock modulator controlling BMAL1 expression through a ROR/REV-ERB-response element-dependent mechanism. Biochemical and Biophysical Research Communications. 469(3). 580–586. 31 indexed citations
15.
16.
Jo, Dong‐Gyu, Hongchan An, Chang Sik Cho, et al.. (2014). Hypoxia-mediated retinal neovascularization and vascular leakage in diabetic retina is suppressed by HIF-1α destabilization by SH-1242 and SH-1280, novel hsp90 inhibitors. Journal of Molecular Medicine. 92(10). 1083–1092. 32 indexed citations
17.
Han, Young Taek, Kyeojin Kim, Hongchan An, et al.. (2014). Pyrazole-5-carboxamides, novel inhibitors of receptor for advanced glycation end products (RAGE). European Journal of Medicinal Chemistry. 79. 128–142. 58 indexed citations
18.
Yun, Hwayoung, Jaehoon Sim, Hongchan An, et al.. (2014). Design and synthesis of a macrosphelide A-biotin chimera. Organic & Biomolecular Chemistry. 12(36). 7127–7127. 6 indexed citations
19.
An, Hongchan, et al.. (2011). Design, synthesis and insight into the structure–activity relationship of 1,3-disubstituted indazoles as novel HIF-1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(21). 6297–6300. 19 indexed citations
20.
Chang, Dong‐Jo, et al.. (2009). Design, synthesis and identification of novel colchicine-derived immunosuppressant. Bioorganic & Medicinal Chemistry Letters. 19(15). 4416–4420. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026